Review





Similar Products

94
MedChemExpress mitogen activated protein kinase mapk signaling pathway
Mitogen Activated Protein Kinase Mapk Signaling Pathway, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mapk+pathway/PD318088/10__34133_slash_cancomm__0048-53-7-23
Average 94 stars, based on 1 article reviews
mitogen activated protein kinase mapk signaling pathway - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

95
RayBiotech inc mouse mapk pathway phosphorylation array c1
Mouse Mapk Pathway Phosphorylation Array C1, supplied by RayBiotech inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mapk+pathway/Human+and+Mouse+AKT+Pathway+Phosphorylation+Array+C1/pm42468084-162-10-16
Average 95 stars, based on 1 article reviews
mouse mapk pathway phosphorylation array c1 - by Bioz Stars, 2026-11
95/100 stars
  Buy from Supplier

96
MedChemExpress mapk pathway inhibitor u0126
Mapk Pathway Inhibitor U0126, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mapk+pathway/U0126-EtOH/pm42287485-49-9-17
Average 96 stars, based on 1 article reviews
mapk pathway inhibitor u0126 - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

86
Jordi Labs mitogen activated protein kinase mapk pathway
Mitogen Activated Protein Kinase Mapk Pathway, supplied by Jordi Labs, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mapk+pathway/activated+kinase+mapk+mitogen+pathway+protein/pm42149426-43-1-16
Average 86 stars, based on 1 article reviews
mitogen activated protein kinase mapk pathway - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

94
TargetMol mitogen activated protein kinase mapk pathway inhibitors
Mitogen Activated Protein Kinase Mapk Pathway Inhibitors, supplied by TargetMol, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mapk+pathway/MAPK+Inhibitor+Library/pm41998662-70-33-42
Average 94 stars, based on 1 article reviews
mitogen activated protein kinase mapk pathway inhibitors - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

98
MedChemExpress mapk erk pathway inhibitors sch772984 hy 50846 ac ce pt ed m
Mapk Erk Pathway Inhibitors Sch772984 Hy 50846 Ac Ce Pt Ed M, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mapk+pathway/SCH772984/pm41988986-311-14-43
Average 98 stars, based on 1 article reviews
mapk erk pathway inhibitors sch772984 hy 50846 ac ce pt ed m - by Bioz Stars, 2026-11
98/100 stars
  Buy from Supplier

97
MedChemExpress p38 mapk pathway
Oba inhibits the <t>TLR4/MyD88/p38</t> MAPK signaling pathway in both in vivo and in vitro experiments. ( A – D ) Molecular docking analysis of Oba with TLR4. ( E – H ) Molecular docking analysis of Oba with MyD88. ( I – L ) Molecular docking analysis of Oba with p38. For each protein, the analysis is presented as: an overall docking pose with the binding region outlined by a red dashed box ( A, E, I ); a close-up view of the binding region ( B, F, J ); a surface representation ( C, G, K ); and a two-dimensional interaction diagram ( D, H, L ). ( M ) Representative Western blot image of TLR4, MyD88, p-p38 and p38 protein in BV-2 cells. The plus and minus signs (+, -) denote the presence or absence of the following reagents in culture: LPS, and 50 μM Oba. ( N ) Quantitative analysis of TLR4 and MyD88 protein levels and p38 phosphorylation in BV-2 cells (n = 5). ( O ) Western blot analysis of TLR4, MyD88, p-p38, and p38 in spinal cord tissues from Sham, SCI, and SCI + Oba (20 mg/kg) groups at 3 days post-SCI. ( P ) Quantitative analysis of TLR4 and MyD88 protein levels and p38 phosphorylation in spinal cord tissues (n = 5). The values are presented as mean ± SD. *p<0.05, **p<0.01, ***p<0.001; NS, not significant.
P38 Mapk Pathway, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mapk+pathway/Phospho-p38+alpha%2FMAPK14+(Thr180%2BTyr182)+Antibody/pmc12994538-112-6-34
Average 97 stars, based on 1 article reviews
p38 mapk pathway - by Bioz Stars, 2026-11
97/100 stars
  Buy from Supplier

95
Cell Signaling Technology Inc mapk pathway sampler kit
Oba inhibits the <t>TLR4/MyD88/p38</t> MAPK signaling pathway in both in vivo and in vitro experiments. ( A – D ) Molecular docking analysis of Oba with TLR4. ( E – H ) Molecular docking analysis of Oba with MyD88. ( I – L ) Molecular docking analysis of Oba with p38. For each protein, the analysis is presented as: an overall docking pose with the binding region outlined by a red dashed box ( A, E, I ); a close-up view of the binding region ( B, F, J ); a surface representation ( C, G, K ); and a two-dimensional interaction diagram ( D, H, L ). ( M ) Representative Western blot image of TLR4, MyD88, p-p38 and p38 protein in BV-2 cells. The plus and minus signs (+, -) denote the presence or absence of the following reagents in culture: LPS, and 50 μM Oba. ( N ) Quantitative analysis of TLR4 and MyD88 protein levels and p38 phosphorylation in BV-2 cells (n = 5). ( O ) Western blot analysis of TLR4, MyD88, p-p38, and p38 in spinal cord tissues from Sham, SCI, and SCI + Oba (20 mg/kg) groups at 3 days post-SCI. ( P ) Quantitative analysis of TLR4 and MyD88 protein levels and p38 phosphorylation in spinal cord tissues (n = 5). The values are presented as mean ± SD. *p<0.05, **p<0.01, ***p<0.001; NS, not significant.
Mapk Pathway Sampler Kit, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mapk+pathway/MAPK+Family+Antibody+Sampler+Kit/pm41831729-93-17-33
Average 95 stars, based on 1 article reviews
mapk pathway sampler kit - by Bioz Stars, 2026-11
95/100 stars
  Buy from Supplier

95
Cell Signaling Technology Inc phospho mapk pathway sampler kit
Oba inhibits the <t>TLR4/MyD88/p38</t> MAPK signaling pathway in both in vivo and in vitro experiments. ( A – D ) Molecular docking analysis of Oba with TLR4. ( E – H ) Molecular docking analysis of Oba with MyD88. ( I – L ) Molecular docking analysis of Oba with p38. For each protein, the analysis is presented as: an overall docking pose with the binding region outlined by a red dashed box ( A, E, I ); a close-up view of the binding region ( B, F, J ); a surface representation ( C, G, K ); and a two-dimensional interaction diagram ( D, H, L ). ( M ) Representative Western blot image of TLR4, MyD88, p-p38 and p38 protein in BV-2 cells. The plus and minus signs (+, -) denote the presence or absence of the following reagents in culture: LPS, and 50 μM Oba. ( N ) Quantitative analysis of TLR4 and MyD88 protein levels and p38 phosphorylation in BV-2 cells (n = 5). ( O ) Western blot analysis of TLR4, MyD88, p-p38, and p38 in spinal cord tissues from Sham, SCI, and SCI + Oba (20 mg/kg) groups at 3 days post-SCI. ( P ) Quantitative analysis of TLR4 and MyD88 protein levels and p38 phosphorylation in spinal cord tissues (n = 5). The values are presented as mean ± SD. *p<0.05, **p<0.01, ***p<0.001; NS, not significant.
Phospho Mapk Pathway Sampler Kit, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mapk+pathway/Phospho-MAPK+Family+Antibody+Sampler+Kit/pm41831729-93-24-33
Average 95 stars, based on 1 article reviews
phospho mapk pathway sampler kit - by Bioz Stars, 2026-11
95/100 stars
  Buy from Supplier

97
Cell Signaling Technology Inc p38 kinase pathway
Oba inhibits the <t>TLR4/MyD88/p38</t> MAPK signaling pathway in both in vivo and in vitro experiments. ( A – D ) Molecular docking analysis of Oba with TLR4. ( E – H ) Molecular docking analysis of Oba with MyD88. ( I – L ) Molecular docking analysis of Oba with p38. For each protein, the analysis is presented as: an overall docking pose with the binding region outlined by a red dashed box ( A, E, I ); a close-up view of the binding region ( B, F, J ); a surface representation ( C, G, K ); and a two-dimensional interaction diagram ( D, H, L ). ( M ) Representative Western blot image of TLR4, MyD88, p-p38 and p38 protein in BV-2 cells. The plus and minus signs (+, -) denote the presence or absence of the following reagents in culture: LPS, and 50 μM Oba. ( N ) Quantitative analysis of TLR4 and MyD88 protein levels and p38 phosphorylation in BV-2 cells (n = 5). ( O ) Western blot analysis of TLR4, MyD88, p-p38, and p38 in spinal cord tissues from Sham, SCI, and SCI + Oba (20 mg/kg) groups at 3 days post-SCI. ( P ) Quantitative analysis of TLR4 and MyD88 protein levels and p38 phosphorylation in spinal cord tissues (n = 5). The values are presented as mean ± SD. *p<0.05, **p<0.01, ***p<0.001; NS, not significant.
P38 Kinase Pathway, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mapk+pathway/Phospho-p38+MAPK+(Thr180%2FTyr182)+Antibody/us12570711-1175-50-63
Average 97 stars, based on 1 article reviews
p38 kinase pathway - by Bioz Stars, 2026-11
97/100 stars
  Buy from Supplier

Image Search Results


Oba inhibits the TLR4/MyD88/p38 MAPK signaling pathway in both in vivo and in vitro experiments. ( A – D ) Molecular docking analysis of Oba with TLR4. ( E – H ) Molecular docking analysis of Oba with MyD88. ( I – L ) Molecular docking analysis of Oba with p38. For each protein, the analysis is presented as: an overall docking pose with the binding region outlined by a red dashed box ( A, E, I ); a close-up view of the binding region ( B, F, J ); a surface representation ( C, G, K ); and a two-dimensional interaction diagram ( D, H, L ). ( M ) Representative Western blot image of TLR4, MyD88, p-p38 and p38 protein in BV-2 cells. The plus and minus signs (+, -) denote the presence or absence of the following reagents in culture: LPS, and 50 μM Oba. ( N ) Quantitative analysis of TLR4 and MyD88 protein levels and p38 phosphorylation in BV-2 cells (n = 5). ( O ) Western blot analysis of TLR4, MyD88, p-p38, and p38 in spinal cord tissues from Sham, SCI, and SCI + Oba (20 mg/kg) groups at 3 days post-SCI. ( P ) Quantitative analysis of TLR4 and MyD88 protein levels and p38 phosphorylation in spinal cord tissues (n = 5). The values are presented as mean ± SD. *p<0.05, **p<0.01, ***p<0.001; NS, not significant.

Journal: Drug Design, Development and Therapy

Article Title: Obacunone Promotes Functional Recovery After Spinal Cord Injury by Attenuating Neuroinflammation by Targeting the TLR4/MyD88/p38 MAPK Pathway

doi: 10.2147/DDDT.S577707

Figure Lengend Snippet: Oba inhibits the TLR4/MyD88/p38 MAPK signaling pathway in both in vivo and in vitro experiments. ( A – D ) Molecular docking analysis of Oba with TLR4. ( E – H ) Molecular docking analysis of Oba with MyD88. ( I – L ) Molecular docking analysis of Oba with p38. For each protein, the analysis is presented as: an overall docking pose with the binding region outlined by a red dashed box ( A, E, I ); a close-up view of the binding region ( B, F, J ); a surface representation ( C, G, K ); and a two-dimensional interaction diagram ( D, H, L ). ( M ) Representative Western blot image of TLR4, MyD88, p-p38 and p38 protein in BV-2 cells. The plus and minus signs (+, -) denote the presence or absence of the following reagents in culture: LPS, and 50 μM Oba. ( N ) Quantitative analysis of TLR4 and MyD88 protein levels and p38 phosphorylation in BV-2 cells (n = 5). ( O ) Western blot analysis of TLR4, MyD88, p-p38, and p38 in spinal cord tissues from Sham, SCI, and SCI + Oba (20 mg/kg) groups at 3 days post-SCI. ( P ) Quantitative analysis of TLR4 and MyD88 protein levels and p38 phosphorylation in spinal cord tissues (n = 5). The values are presented as mean ± SD. *p<0.05, **p<0.01, ***p<0.001; NS, not significant.

Article Snippet: To investigate the role of the p38 MAPK pathway in the anti-inflammatory effects of Oba, BV-2 cells were pre-treated for 3 hours with 50 μM Oba, 10 μM SB203580 (a p38 MAPK inhibitor; HY-10256, MCE, China), or a combination of both, prior to stimulation with LPS for 24 hours.

Techniques: In Vivo, In Vitro, Binding Assay, Western Blot, Phospho-proteomics

Oba attenuates inflammation by targeting the TLR4/MyD88/p38 MAPK pathway in BV-2 microglial cells. ( A ) Representative Western blot of TLR4 expression in BV-2 cells transfected with a TLR4 overexpression plasmid (pcDNA3.1-TLR4) or an empty vector. The plus and minus signs (+, -) denote the presence or absence of the following reagents in culture: empty plasmid (Oe-NC), and TLR4 overexpression plasmid (Oe-TLR4). ( B ) Quantitative analysis of TLR4 protein levels (n = 5). ( C ) Western blot images of iNOS, TLR4, TNFα and IL-1β protein expression in BV-2 cells. The plus and minus signs (+, -) denote the presence or absence of the following treatments in culture: Oe-NC, Oe-TLR4, LPS, and Oba. ( D – G ) Quantitative analysis of iNOS, TLR4, TNFα and IL-1β protein levels (n = 5). ( H ) Representative Western blot images of iNOS, TNFα, IL-1β, p-p38 and p38 in BV-2 cells. The plus and minus signs (+, -) denote the presence or absence of the following reagents in culture: LPS, Oba, and SB203580. ( I – L ) Quantitative analysis of iNOS, TNFα, IL-1β protein levels and p38 phosphorylation (n = 5). The values are presented as mean ± SD. *p<0.05, **p<0.01, ***p<0.001; NS, not significant.

Journal: Drug Design, Development and Therapy

Article Title: Obacunone Promotes Functional Recovery After Spinal Cord Injury by Attenuating Neuroinflammation by Targeting the TLR4/MyD88/p38 MAPK Pathway

doi: 10.2147/DDDT.S577707

Figure Lengend Snippet: Oba attenuates inflammation by targeting the TLR4/MyD88/p38 MAPK pathway in BV-2 microglial cells. ( A ) Representative Western blot of TLR4 expression in BV-2 cells transfected with a TLR4 overexpression plasmid (pcDNA3.1-TLR4) or an empty vector. The plus and minus signs (+, -) denote the presence or absence of the following reagents in culture: empty plasmid (Oe-NC), and TLR4 overexpression plasmid (Oe-TLR4). ( B ) Quantitative analysis of TLR4 protein levels (n = 5). ( C ) Western blot images of iNOS, TLR4, TNFα and IL-1β protein expression in BV-2 cells. The plus and minus signs (+, -) denote the presence or absence of the following treatments in culture: Oe-NC, Oe-TLR4, LPS, and Oba. ( D – G ) Quantitative analysis of iNOS, TLR4, TNFα and IL-1β protein levels (n = 5). ( H ) Representative Western blot images of iNOS, TNFα, IL-1β, p-p38 and p38 in BV-2 cells. The plus and minus signs (+, -) denote the presence or absence of the following reagents in culture: LPS, Oba, and SB203580. ( I – L ) Quantitative analysis of iNOS, TNFα, IL-1β protein levels and p38 phosphorylation (n = 5). The values are presented as mean ± SD. *p<0.05, **p<0.01, ***p<0.001; NS, not significant.

Article Snippet: To investigate the role of the p38 MAPK pathway in the anti-inflammatory effects of Oba, BV-2 cells were pre-treated for 3 hours with 50 μM Oba, 10 μM SB203580 (a p38 MAPK inhibitor; HY-10256, MCE, China), or a combination of both, prior to stimulation with LPS for 24 hours.

Techniques: Western Blot, Expressing, Transfection, Over Expression, Plasmid Preparation, Phospho-proteomics